STAT

JUNE 11, 2024

As a co-leader of the team at the National Institutes of Health that developed technologies powering a number of Covid-19 vaccines, I often speak publicly about vaccine science, even though I no longer work for the government. There is no denying the millions of lives that Covid-19 vaccines saved.

Vaccines 363

Vaccines 363

STAT

MARCH 8, 2025

It is also eminently vaccine-preventable. The live-attenuated measles vaccine was developed in the late 1950s — catalyzed by the technological breakthroughs that enabled polio vaccine development — and licensed in 1963.

Vaccines 297

Vaccines Hospitals 297

STAT

MARCH 19, 2025

I started my medical career in the early 1990s as a vaccine nihilist. I offered vaccines to my patients and was adherent to the routine schedules, but certainly did not go out of my way to encourage or cajole. I neglected to have my first child vaccinated against chickenpox; the scars are still present.

Vaccines 285

Vaccines Immunity Immunization 285

STAT

SEPTEMBER 11, 2023

The Food and Drug Administration announced Monday that it had greenlit two   updated Covid-19 booster shots in people as young as 6 months old, triggering a process that could see the Moderna and Pfizer-BioNTech vaccines become available in doctors’ offices, clinics, and pharmacies later this week. Read the rest…

Vaccines 363

Vaccines 363

STAT

MAY 13, 2024

The number of children who received their routine vaccinations declined during the pandemic, so public health officials have been focusing on getting kids back up to date. They found that adult vaccination programs paid for themselves many times over, returning up to 19 times the initial investment in societal benefits.

Vaccines 362

Vaccines Immunity Immunization 362

STAT

JANUARY 25, 2024

A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.

Vaccines 364

Vaccines 364

STAT

JULY 2, 2024

Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company announced in a statement Tuesday. Read the rest…

Vaccines 350

Vaccines Dosage 350

STAT

MARCH 3, 2025

In the spring of 2009, the first flu pandemic in four decades began. Caused by an H1N1 virus that emerged from pigs, likely in Mexico, it spread quickly around the globe. The world got lucky in 2009.

Immunity 345

Immunity Immunization Vaccines 345

STAT

MARCH 3, 2025

Even more, there is a highly effective vaccine against HPV, the virus that causes most cervical cancer diagnoses. Along with lung, breast, and colorectal cancer, it has screening tests to find precancerous changes that can be treated before full-blown cancer develops.

Vaccines 348

Vaccines 348

STAT

JUNE 17, 2024

The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older.

Vaccines 363

Vaccines Hospitals 363

STAT

MARCH 5, 2025

ACIP advises the director of the Centers for Diseases Control and Prevention on how to use vaccines in the U.S. The Advisory Committee on Immunization Practices (ACIP), has served the American people since 1964.

Immunity 323

Immunity Immunization Vaccines 323

STAT

JANUARY 18, 2023

Yet another experimental HIV vaccine has failed. The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. Read the rest…

Vaccines 363

Vaccines 363

STAT

OCTOBER 4, 2024

Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S. government official confirmed on Friday.

Vaccines 364

Vaccines 364

STAT

MAY 10, 2024

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.     The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot.

Vaccines 364

Vaccines 364

STAT

OCTOBER 3, 2023

The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option. based company, which has struggled to claim a share of the now dwindling Covid vaccine market — globally and within the United States.

Vaccines 364

Vaccines 364

STAT

MAY 9, 2024

Weeks after the global public health community sounded the alarm on the shortage of cholera vaccine, the World Health Organization moved to prequalify a new cholera vaccine last month. The vaccine is a simplified version of the two existing oral vaccines, both produced by Korean vaccine manufacturer EuBiologics Co.

Vaccines 350

Vaccines 350

STAT

JUNE 14, 2024

Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox.

Vaccines 343

Vaccines Immunity Immunization 343

STAT

FEBRUARY 1, 2024

A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 1 subvariant, which emerged after the vaccine was made. 1.5 — and the JN.1

Vaccines 364

Vaccines 364

STAT

OCTOBER 13, 2023

6 months and older receive an updated Covid vaccine targeting the XBB.1.5 Since then, some notable voices, including Paul Offit , have publicly questioned whether the updated vaccine is needed for those who are not in a high-risk group. Last month, the Centers for Disease Control and Prevention recommended that everyone in the U.S.

Vaccines 364

Vaccines 364

STAT

JUNE 7, 2024

The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50. Arexvy, which was the first RSV vaccine approved , now becomes the first to be available to adults under the age of 60 who are not pregnant.

Vaccines 363

Vaccines 363

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. The promise has long been an affordable, personalized cancer vaccine that could train the immune system to recognize proteins from cancer cells and, subsequently, destroy the tumor.

Vaccines 364

Vaccines Immunity Immunization Drug Development 364

STAT

SEPTEMBER 4, 2024

The emergence of a second mpox outbreak in which the virus is spreading from person-to-person, as well as a sharp increase in overall cases of the disease in several African countries, is straining the world’s capacity to make and distribute vaccine to battle the threat. Read the rest…

Vaccines 353

Vaccines 353

STAT

AUGUST 16, 2024

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply. Read the rest…

Vaccines 363

Vaccines 363

STAT

JANUARY 21, 2024

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections.

Vaccines 364

Vaccines Immunity Immunization 364

STAT

SEPTEMBER 20, 2024

The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration.    Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so. 

Vaccines 363

Vaccines 363

STAT

OCTOBER 24, 2023

People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. FluMist is only licensed for use in children and adults from the age of 2 to 49 years old. Read the rest…

Vaccines 363

Vaccines 363

STAT

FEBRUARY 3, 2025

Vaccines do not cause autism. You’ve almost certainly read that before — probably hundreds of times. But many people do not believe it, perhaps because too often it is repeated without a real explanation of how we know that. So here is an attempt to offer that explanation. Read the rest…

Vaccines 364

Vaccines 364

STAT

OCTOBER 5, 2023

The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline. Read the rest…

Vaccines 361

Vaccines 361

STAT

DECEMBER 6, 2023

A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in Harare, Zimbabwe. The trial, known as PrEPVacc, was testing two different vaccine regimens on about 1,500 volunteers in East and Southern Africa.   Read the rest…

Vaccines 363

Vaccines Drug Development 363

STAT

SEPTEMBER 26, 2023

The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021.

Vaccines 363

Vaccines 363

STAT

AUGUST 22, 2024

regulators approved  updated Covid-19 vaccines  on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. manufacturer, Novavax, expects its updated vaccine version to be available a little later. WASHINGTON — U.S. A third U.S.

Vaccines 361

Vaccines 361

STAT

JUNE 18, 2024

Around the world, the viral infection kills about 70,000 people a year — and since as early as 2015, groups including Gavi, the Vaccine Alliance, have had plans to shore up vaccine efforts to reduce the number. On Thursday, Gavi announced a plan to expand global access to human rabies vaccines, reaching over 50 countries.

Vaccines 325

Vaccines 325

STAT

DECEMBER 13, 2022

An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant Merck reduced the risk that melanoma would return after surgery or that patients would die by 44%, the company said.

Vaccines 360

Vaccines 360

STAT

JANUARY 12, 2023

kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S.

Vaccines 363

Vaccines 363

STAT

FEBRUARY 27, 2024

An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. Those numbers will almost certainly rise amid the worst vaccine shortage since an oral vaccine was introduced in the 1990s.

Vaccines 363

Vaccines 363

STAT

JUNE 5, 2024

LONDON — Finland is preparing to offer vaccines to people at risk of exposure to an avian influenza strain spreading among farmed and wild animals, health officials there said, potentially becoming the first country to take such a step as concerns about the threat the virus poses to people intensify.

Vaccines 364

Vaccines 364

STAT

AUGUST 16, 2024

Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response against one type of influenza, influenza B, in a Phase 3 trial, a setback for the vaccine. ” Continue to STAT+ to read the full story…

Vaccines 346

Vaccines Immunity Immunization 346